Tiger game

Like
Comment
Favorite

Kaslim
2021-06-25

Tiger game

Who is hyping Pien Tze Huang?

“抢购与炒作齐飞”，今日的神药片仔癀一如2020年的神酒贵州茅台。媒体报道，近日，因为消费者疯抢，大量线下门店的片仔癀已经缺货，在淘宝、京东等电商平台，片仔癀官方旗舰店的药品均已售罄。淘宝“片仔癀大

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

Top
Latest

No comments yet

Most Discussed

{"i18n":{"language":"en_US"},"data":{"magic":2,"id":122766396,"tweetId":"122766396","gmtCreate":1624633728315,"gmtModify":1703842392771,"author":{"id":3569896467959373,"idStr":"3569896467959373","authorId":3569896467959373,"authorIdStr":"3569896467959373","name":"Kaslim","avatar":"https://static.tigerbbs.com/f82c85a933438b27edc2f005ba118976","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>Tiger game&nbsp;</body></html>","htmlText":"<html><head></head><body>Tiger game&nbsp;</body></html>","text":"Tiger game","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/122766396","repostId":1186640720,"repostType":4,"repost":{"id":"1186640720","kind":"news","pubTimestamp":1624608318,"share":"https://ttm.financial/m/news/1186640720?lang=en_US&edition=fundamental","pubTime":"2021-06-25 16:05","market":"sh","language":"zh","title":"Who is hyping Pien Tze Huang?","url":"https://stock-news.laohu8.com/highlight/detail?id=1186640720","media":"智通财经APP","summary":"“抢购与炒作齐飞”，今日的神药片仔癀一如2020年的神酒贵州茅台。\n媒体报道，近日，因为消费者疯抢，大量线下门店的片仔癀已经缺货，在淘宝、京东等电商平台，片仔癀官方旗舰店的药品均已售罄。淘宝“片仔癀大","content":"\"Snapping up and hyping Qi Fei\", today's magic medicine Pien Tze Huang is just like the magic wine Kweichow Moutai in 2020.According to media reports, recently, Pien Tze Huang in a large number of offline stores has been out of stock due to consumers' rush. On Taobao, JD.com and other e-commerce platforms, the medicines in the official flagship store of Pien Tze Huang have been sold out. Taobao's \"Pien Tze Huang Pharmacy Flagship Store\" customer service stated that the replenishment time cannot be determined, and it is recommended to collect the products first. The price of a single piece of Pien Tze Huang sold by other merchants is as high as 1,000 yuan.Pien Tze Huang's stock price has also been rising all the way, soaring from 100 yuan in early 2020 to more than 400 yuan at present. On June 25, it broke through the 450 yuan mark.1、Hoarding? Who is snapping up Pien Tze Huang?Pien Tze Huang is a drug for liver diseases, which is mainly suitable for acute and chronic viral hepatitis caused by heat toxicity and blood stasis. It has both medical and health care functions. Simply put, Pien Tze Huang has the effect of treating fatty liver and alcoholic liver.Since Pien Tze Huang went public, it has continuously raised prices 19 times. Among them, the domestic retail price increased 9 times from 2004 to 2020, from the retail price of 325 yuan to 590 yuan, an increase of 82%.How did this wave of hype about Pien Tze Huang come about?One view is that Pien Tze Huang is scarce.Is Pien Tze Huang really scarce?Affected by the epidemic, since last year, many consumers' demand for natural medicinal materials has increased, resulting in the price of natural musk rising from 300,000 yuan per kilogram to 400,000 yuan in the past two years. The ingredients of Pien Tze Huang are bezoar, musk, Panax notoginseng and snake bile, and musk alone accounts for 55% of the total cost.Some people think that the contradiction in the supply of raw materials in Pien Tze Huang is more prominent than in previous years. As a scarce variety, Pien Tze Huang is in short supply, and the price is getting higher and higher, and the higher it is, the more speculated it is, resulting in an investment \"herd effect\".Regarding the reasons for the latest price increase, Pien Tze Huang announced in January 2020 that in view of the increase in main raw materials and labor costs, the company decided to increase the domestic retail price of the leading product Pien Tze Huang lozenges from 530 yuan/tablet to 590 yuan/tablet from the date of the announcement, and the supply price was correspondingly increased by about 40 yuan/tablet.However, according to a research report published by Southwest Securities on February 7, 2021, Pien Tze Huang is currently promoting artificial musk deer breeding to make up for the shortage of scarce raw materials. The Shaanxi breeding base raises more than 10,000 musk deer heads, with an estimated annual output of more than 100 kilograms. Musk and bezoar can meet 3 years of production capacity expansion.In other words, the so-called scarcity of raw materials is temporary and does not support the hype of Pien Tze Huang.Is there a scalper hype?At the end of April, some netizens revealed that Pien Tze Huang has officially entered the purchase restriction policy from May 2021, the strictest purchase restriction order in history. In that month, you can buy it in the experience hall with your personal ID number and prescription. One person is limited to 2 pills a month, which meets the use of the month. The dosage ensures that customers who have taken drugs for a long time will not stop taking drugs.At present, Pien Tze Huang offline stores in many places implement purchase restrictions. You need to leave your phone number and ID number to make an appointment, and even offline stores require consumers to \"match\" the purchase, that is, if you want to buy Pien Tze Huang, you have to buy other high-priced medicines.Analyst Zhu Danpeng said that the sudden shortage of Pien Tze Huang is not unrelated to the hype. In the south, especially in the southeast coastal areas, some consumers think that Pien Tze Huang has health effects, and its price remains high all the year round, which makes it have some gift attributes.Some speculators snapped up Pien Tze Huang and waited for the price to rise, and then sold it to earn huge profits.A Pien Tze Huang offline store in Shanghai told the media, \"Not many people bought this medicine before. Two or three months ago, scalpers suddenly began to buy it in large quantities. The store had no choice but to restrict purchases and was only open to members and old customers.\"Are drugs hyped in conjunction with the capital market?Chuancai Securities revealed that there may be hot money involved in Pien Tze Huang speculation.The strategy research team of Chuancai Securities believes that behind the sudden imbalance between supply and demand, it is inevitable that there are people who maliciously hoard goods, maliciously speculate, and even take the opportunity to make profits in the securities market.In fact, such hype routines are not new. In June this year, a user certified by Weibo as the general manager of an asset management company revealed, \"A liquor company invites dealers to buy equivalent stocks every time they buy wine. In the end, the stock price doubled, which is equivalent to the dealer getting wine at zero cost. The wine can be kept for several years and sold slowly.\"2、Public Offering of Fund has emptied Pien Tze Huang?Different from 2020, when public offering institutions joined forces to promote liquor leaders such as Kweichow Moutai and Wuliangye, this time, paradoxically, public offering funds may have perfectly stepped on Pien Tze Huang, the \"Moutai in Medicine\".Wind data shows that at the end of the fourth quarter of 2020, there were 25 Public Offering of Fund holding more than 100,000 shares of Pien Tze Huang: a total of about 26,782,400 shares were held, accounting for about 4.44% of the circulating A shares. Among them, there are many \"top fund managers\" Ge Lan, Liu Gesong, Qu Yang and others.However, after experiencing the sharp fluctuation of white horse stocks after the Spring Festival, the public data in the first quarter showed that the number of shares held by the top 25 institutions dropped sharply to 10,021,200 shares, with a reduction of more than 60%, accounting for only 1.65% of the circulation ratio of A shares.At the end of 2020, a total of 101 institutional investors held shares. At the end of the first quarter of this year, the number of institutional investors dropped sharply to 41.In the quarter of 2021, Pien Tze Huang also experienced a stock price adjustment. Among them, from February 18 to March 9, the stock price fell from 404 yuan to 239 yuan, nearly halved.Judging from public data, most Public Offering of Fund sold Pien Tze Huang in the adjustment in the first quarter of 2021.However, the main rise in Pien Tze Huang's stock price was in the second quarter of 2021. In this process, did Public Offering of Fund \"eat back grass\" and increase its positions in Pien Tze Huang? At present, the interim reports of Public Offering of Fund and listed companies have not yet been released, so we don't know.In the first quarter of 2021, a few Public Offering of Fund chose to stick to or even increase their positions. China Universal Value Select A continued to hold 1.5 million shares without selling one share, while CEIBS Gulen, known as the \"goddess of medicine\" in the industry, bucked the trend and aggressively increased its positions. At the end of the fourth quarter of last year, it only held 272,800 shares of Pien Tze Huang, but at the end of the first quarter, it already held 2,214,900 shares, which was nearly 10 times higher, showing its strong optimism about the company. Like Gulen, the new GF Healthcare (1,187,200 shares) and Social Security 101 portfolio (1,041,300 shares) increased their positions in the first quarter, while Yinhua Fuyu Theme also increased its positions by 1,199,800 shares to 2,749,800 shares in the first quarter, ranking the sixth largest shareholder.3、Is Lin Yuan the man behind Pien Tze Huang?In the 2018 semi-annual report, the private equity fund owned by private equity tycoon Lin Yuan appeared among the top ten shareholders of Pien Tze Huang with a shareholding ratio of 0.64%. As of the end of June 2020, its three private equity funds held a total of 8.837 million shares of Pien Tze Huang.However, in the third quarter of 2020, the news that \"Linyuan reduced its holdings of Pien Tze Huang\" came out. As of the first quarter of 2021, Linyuan's three private equity funds were no longer among the top ten shareholders.On June 9, 2021, Lin Yuan sent representatives to attend the Pien Tze Huang shareholders' meeting. At the meeting, it was stated, \"I have invested in Pien Tze Huang stocks since 2005, and so far no share has been sold.\" Lin Yuan had previously said that he only split his positions.Lin Yuan also sent a warm thank-you letter to Pien Tze Huang, which still expressed strong optimism:\"Linyuan and Linyuan Investment have not sold a share since they bought Pien Tze Huang in 2005. Especially in my country's COVID-19 pandemic during the trade war, including this year, they have been investing heavily, adhering to long-termism, firmly optimistic about the Chinese medicine industry, and being bullish on China. Believe in the national destiny, believe that Pien Tze Huang is a great company. Believe in excellent management. I also wish the company well under the leadership of Mr. Pan. Climb the peak bravely and become China's business card and a luxury brand in the world! \"Previously, on April 21, 2018, Lin Yuan even declared at the investment report meeting that Pien Tze Huang could be \"brought back to life\".\"Recently I chose a Pien Tze Huang. It is also a pharmaceutical enterprise, which is from Fujian. There are two treasures in Zhangzhou, one is narcissus and the other is Pien Tze Huang. After the Fujian people die, the locals have to put this medicine in and try if they can survive.\"Regarding this \"speculation\" of Pien Tze Huang, Lin Yuan even publicly stated that \"they will eventually sell the price of two bottles of Maotai.\"<img src=\"https://static.tigerbbs.com/a6602d2149a718945e18d3b0fdc92cfa\" tg-width=\"608\" tg-height=\"712\" referrerpolicy=\"no-referrer\">4、、Can the price increase of Pien Tze Huang continue?Can Pien Tze Huang really \"sell for the price of two bottles of Maotai\"?On June 9, 2021, at the Pien Tze Huang shareholders' meeting, the company stated that it has always been more cautious in dealing with price increases and does not pursue excessive profits. I don't agree with everyone comparing the prices of Pien Tze Huang with Moutai. Maotai is a grain product and belongs to food; Pien Tze Huang is a drug. When it comes to the pricing and price increase of drugs, we must be more cautious and consider social responsibilities more. We cannot follow the market immediately.In fact, as a medicine, Pien Tze Huang always faces medical price control. Under the general trend of centralized pharmaceutical procurement, it is impossible for any \"magic medicine\" to sell at sky-high prices.On June 25, Pien Tze Huang responded to the recent phenomenon that its Pien Tze Huang lozenges are \"hard to find\" on the interactive platform, saying that the company's production and operation are in a normal state at present. In response to the recent market situation, the company has taken three measures to resolutely maintain market order.Although the stock price has soared, judging from the financial report data in recent years, Pien Tze Huang's revenue growth rate in 2017 was the fastest, reaching 60.85%, but then the revenue growth rate began to decline year by year, and by 2020 it dropped to nearly five years. The lowest point of the year is only 13.78%.However, Pien Tze Huang's net profit has always remained at a high level. After the price increase in 2020, the revenue growth rate dropped to the lowest level in five years, but the net profit growth rate was only 1 percentage point behind that in 2019.In fact, Pien Tze Huang's research and development expenses account for a very low proportion. The company's research and development expenses from 2018 to 2020 were 100 million yuan, 119 million yuan, and 97.55 million yuan respectively, accounting for 2.12%, 2.09%, and 1.5% of operating income respectively.Pien Tze Huang is an \"exclusive business\". Pien Tze Huang and Yunnan Baiyao are the only two national first-class protected varieties of traditional Chinese medicine. State secret formula medicinal materials. Therefore, Pien Tze Huang may not have much motivation for research and development, and it will not make mistakes without trial and error. It is safest to have ready-made ones for reference.<img src=\"https://static.tigerbbs.com/d5efd050b5584873992f4b1d5f5b5cfb\" tg-width=\"767\" tg-height=\"439\" referrerpolicy=\"no-referrer\">","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Who is hyping Pien Tze Huang?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWho is hyping Pien Tze Huang?\n</h2>\n<h4 class=\"meta\">\n\n智通财经APP2021-06-25 16:05\n\n</h4>\n</header>\n<article>\n\"Snapping up and hyping Qi Fei\", today's magic medicine Pien Tze Huang is just like the magic wine Kweichow Moutai in 2020.According to media reports, recently, Pien Tze Huang in a large number of offline stores has been out of stock due to consumers' rush. On Taobao, JD.com and other e-commerce platforms, the medicines in the official flagship store of Pien Tze Huang have been sold out. Taobao's \"Pien Tze Huang Pharmacy Flagship Store\" customer service stated that the replenishment time cannot be determined, and it is recommended to collect the products first. The price of a single piece of Pien Tze Huang sold by other merchants is as high as 1,000 yuan.Pien Tze Huang's stock price has also been rising all the way, soaring from 100 yuan in early 2020 to more than 400 yuan at present. On June 25, it broke through the 450 yuan mark.1、Hoarding? Who is snapping up Pien Tze Huang?Pien Tze Huang is a drug for liver diseases, which is mainly suitable for acute and chronic viral hepatitis caused by heat toxicity and blood stasis. It has both medical and health care functions. Simply put, Pien Tze Huang has the effect of treating fatty liver and alcoholic liver.Since Pien Tze Huang went public, it has continuously raised prices 19 times. Among them, the domestic retail price increased 9 times from 2004 to 2020, from the retail price of 325 yuan to 590 yuan, an increase of 82%.How did this wave of hype about Pien Tze Huang come about?One view is that Pien Tze Huang is scarce.Is Pien Tze Huang really scarce?Affected by the epidemic, since last year, many consumers' demand for natural medicinal materials has increased, resulting in the price of natural musk rising from 300,000 yuan per kilogram to 400,000 yuan in the past two years. The ingredients of Pien Tze Huang are bezoar, musk, Panax notoginseng and snake bile, and musk alone accounts for 55% of the total cost.Some people think that the contradiction in the supply of raw materials in Pien Tze Huang is more prominent than in previous years. As a scarce variety, Pien Tze Huang is in short supply, and the price is getting higher and higher, and the higher it is, the more speculated it is, resulting in an investment \"herd effect\".Regarding the reasons for the latest price increase, Pien Tze Huang announced in January 2020 that in view of the increase in main raw materials and labor costs, the company decided to increase the domestic retail price of the leading product Pien Tze Huang lozenges from 530 yuan/tablet to 590 yuan/tablet from the date of the announcement, and the supply price was correspondingly increased by about 40 yuan/tablet.However, according to a research report published by Southwest Securities on February 7, 2021, Pien Tze Huang is currently promoting artificial musk deer breeding to make up for the shortage of scarce raw materials. The Shaanxi breeding base raises more than 10,000 musk deer heads, with an estimated annual output of more than 100 kilograms. Musk and bezoar can meet 3 years of production capacity expansion.In other words, the so-called scarcity of raw materials is temporary and does not support the hype of Pien Tze Huang.Is there a scalper hype?At the end of April, some netizens revealed that Pien Tze Huang has officially entered the purchase restriction policy from May 2021, the strictest purchase restriction order in history. In that month, you can buy it in the experience hall with your personal ID number and prescription. One person is limited to 2 pills a month, which meets the use of the month. The dosage ensures that customers who have taken drugs for a long time will not stop taking drugs.At present, Pien Tze Huang offline stores in many places implement purchase restrictions. You need to leave your phone number and ID number to make an appointment, and even offline stores require consumers to \"match\" the purchase, that is, if you want to buy Pien Tze Huang, you have to buy other high-priced medicines.Analyst Zhu Danpeng said that the sudden shortage of Pien Tze Huang is not unrelated to the hype. In the south, especially in the southeast coastal areas, some consumers think that Pien Tze Huang has health effects, and its price remains high all the year round, which makes it have some gift attributes.Some speculators snapped up Pien Tze Huang and waited for the price to rise, and then sold it to earn huge profits.A Pien Tze Huang offline store in Shanghai told the media, \"Not many people bought this medicine before. Two or three months ago, scalpers suddenly began to buy it in large quantities. The store had no choice but to restrict purchases and was only open to members and old customers.\"Are drugs hyped in conjunction with the capital market?Chuancai Securities revealed that there may be hot money involved in Pien Tze Huang speculation.The strategy research team of Chuancai Securities believes that behind the sudden imbalance between supply and demand, it is inevitable that there are people who maliciously hoard goods, maliciously speculate, and even take the opportunity to make profits in the securities market.In fact, such hype routines are not new. In June this year, a user certified by Weibo as the general manager of an asset management company revealed, \"A liquor company invites dealers to buy equivalent stocks every time they buy wine. In the end, the stock price doubled, which is equivalent to the dealer getting wine at zero cost. The wine can be kept for several years and sold slowly.\"2、Public Offering of Fund has emptied Pien Tze Huang?Different from 2020, when public offering institutions joined forces to promote liquor leaders such as Kweichow Moutai and Wuliangye, this time, paradoxically, public offering funds may have perfectly stepped on Pien Tze Huang, the \"Moutai in Medicine\".Wind data shows that at the end of the fourth quarter of 2020, there were 25 Public Offering of Fund holding more than 100,000 shares of Pien Tze Huang: a total of about 26,782,400 shares were held, accounting for about 4.44% of the circulating A shares. Among them, there are many \"top fund managers\" Ge Lan, Liu Gesong, Qu Yang and others.However, after experiencing the sharp fluctuation of white horse stocks after the Spring Festival, the public data in the first quarter showed that the number of shares held by the top 25 institutions dropped sharply to 10,021,200 shares, with a reduction of more than 60%, accounting for only 1.65% of the circulation ratio of A shares.At the end of 2020, a total of 101 institutional investors held shares. At the end of the first quarter of this year, the number of institutional investors dropped sharply to 41.In the quarter of 2021, Pien Tze Huang also experienced a stock price adjustment. Among them, from February 18 to March 9, the stock price fell from 404 yuan to 239 yuan, nearly halved.Judging from public data, most Public Offering of Fund sold Pien Tze Huang in the adjustment in the first quarter of 2021.However, the main rise in Pien Tze Huang's stock price was in the second quarter of 2021. In this process, did Public Offering of Fund \"eat back grass\" and increase its positions in Pien Tze Huang? At present, the interim reports of Public Offering of Fund and listed companies have not yet been released, so we don't know.In the first quarter of 2021, a few Public Offering of Fund chose to stick to or even increase their positions. China Universal Value Select A continued to hold 1.5 million shares without selling one share, while CEIBS Gulen, known as the \"goddess of medicine\" in the industry, bucked the trend and aggressively increased its positions. At the end of the fourth quarter of last year, it only held 272,800 shares of Pien Tze Huang, but at the end of the first quarter, it already held 2,214,900 shares, which was nearly 10 times higher, showing its strong optimism about the company. Like Gulen, the new GF Healthcare (1,187,200 shares) and Social Security 101 portfolio (1,041,300 shares) increased their positions in the first quarter, while Yinhua Fuyu Theme also increased its positions by 1,199,800 shares to 2,749,800 shares in the first quarter, ranking the sixth largest shareholder.3、Is Lin Yuan the man behind Pien Tze Huang?In the 2018 semi-annual report, the private equity fund owned by private equity tycoon Lin Yuan appeared among the top ten shareholders of Pien Tze Huang with a shareholding ratio of 0.64%. As of the end of June 2020, its three private equity funds held a total of 8.837 million shares of Pien Tze Huang.However, in the third quarter of 2020, the news that \"Linyuan reduced its holdings of Pien Tze Huang\" came out. As of the first quarter of 2021, Linyuan's three private equity funds were no longer among the top ten shareholders.On June 9, 2021, Lin Yuan sent representatives to attend the Pien Tze Huang shareholders' meeting. At the meeting, it was stated, \"I have invested in Pien Tze Huang stocks since 2005, and so far no share has been sold.\" Lin Yuan had previously said that he only split his positions.Lin Yuan also sent a warm thank-you letter to Pien Tze Huang, which still expressed strong optimism:\"Linyuan and Linyuan Investment have not sold a share since they bought Pien Tze Huang in 2005. Especially in my country's COVID-19 pandemic during the trade war, including this year, they have been investing heavily, adhering to long-termism, firmly optimistic about the Chinese medicine industry, and being bullish on China. Believe in the national destiny, believe that Pien Tze Huang is a great company. Believe in excellent management. I also wish the company well under the leadership of Mr. Pan. Climb the peak bravely and become China's business card and a luxury brand in the world! \"Previously, on April 21, 2018, Lin Yuan even declared at the investment report meeting that Pien Tze Huang could be \"brought back to life\".\"Recently I chose a Pien Tze Huang. It is also a pharmaceutical enterprise, which is from Fujian. There are two treasures in Zhangzhou, one is narcissus and the other is Pien Tze Huang. After the Fujian people die, the locals have to put this medicine in and try if they can survive.\"Regarding this \"speculation\" of Pien Tze Huang, Lin Yuan even publicly stated that \"they will eventually sell the price of two bottles of Maotai.\"<img src=\"https://static.tigerbbs.com/a6602d2149a718945e18d3b0fdc92cfa\" tg-width=\"608\" tg-height=\"712\" referrerpolicy=\"no-referrer\">4、、Can the price increase of Pien Tze Huang continue?Can Pien Tze Huang really \"sell for the price of two bottles of Maotai\"?On June 9, 2021, at the Pien Tze Huang shareholders' meeting, the company stated that it has always been more cautious in dealing with price increases and does not pursue excessive profits. I don't agree with everyone comparing the prices of Pien Tze Huang with Moutai. Maotai is a grain product and belongs to food; Pien Tze Huang is a drug. When it comes to the pricing and price increase of drugs, we must be more cautious and consider social responsibilities more. We cannot follow the market immediately.In fact, as a medicine, Pien Tze Huang always faces medical price control. Under the general trend of centralized pharmaceutical procurement, it is impossible for any \"magic medicine\" to sell at sky-high prices.On June 25, Pien Tze Huang responded to the recent phenomenon that its Pien Tze Huang lozenges are \"hard to find\" on the interactive platform, saying that the company's production and operation are in a normal state at present. In response to the recent market situation, the company has taken three measures to resolutely maintain market order.Although the stock price has soared, judging from the financial report data in recent years, Pien Tze Huang's revenue growth rate in 2017 was the fastest, reaching 60.85%, but then the revenue growth rate began to decline year by year, and by 2020 it dropped to nearly five years. The lowest point of the year is only 13.78%.However, Pien Tze Huang's net profit has always remained at a high level. After the price increase in 2020, the revenue growth rate dropped to the lowest level in five years, but the net profit growth rate was only 1 percentage point behind that in 2019.In fact, Pien Tze Huang's research and development expenses account for a very low proportion. The company's research and development expenses from 2018 to 2020 were 100 million yuan, 119 million yuan, and 97.55 million yuan respectively, accounting for 2.12%, 2.09%, and 1.5% of operating income respectively.Pien Tze Huang is an \"exclusive business\". Pien Tze Huang and Yunnan Baiyao are the only two national first-class protected varieties of traditional Chinese medicine. State secret formula medicinal materials. Therefore, Pien Tze Huang may not have much motivation for research and development, and it will not make mistakes without trial and error. It is safest to have ready-made ones for reference.<img src=\"https://static.tigerbbs.com/d5efd050b5584873992f4b1d5f5b5cfb\" tg-width=\"767\" tg-height=\"439\" referrerpolicy=\"no-referrer\">\n<div class=\"bt-text\">\n\n\n source：<a href=\"https://mp.weixin.qq.com/s/fPg__P2D5g2Ud8-8ZahI9Q\">智通财经APP</a>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","relate_stocks":{"600436":"片仔癀"},"source_url":"https://mp.weixin.qq.com/s/fPg__P2D5g2Ud8-8ZahI9Q","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186640720","content_text":"“抢购与炒作齐飞”，今日的神药片仔癀一如2020年的神酒贵州茅台。\n媒体报道，近日，因为消费者疯抢，大量线下门店的片仔癀已经缺货，在淘宝、京东等电商平台，片仔癀官方旗舰店的药品均已售罄。淘宝“片仔癀大药房旗舰店”客服表示，补货时间无法确定，建议先收藏商品。其他商家售卖的片仔癀单粒价格则高达千元。\n片仔癀的股价也一路水涨船高，从2020年初的100元飙升至目前的400元以上，6月25日，突破450元大关。\n1、囤积居奇？谁在抢购片仔癀？\n片仔癀是一种肝病用药，主要适用于热毒血瘀所致急慢性病毒性肝炎，同时具备医用和保健功能。简单地说，片仔癀有治疗脂肪肝、酒精肝的作用。\n自片仔癀上市以来，已经持续进行了19次提价。其中，2004年到2020年国内零售价一共提价9次，从325元的零售价提升到了590元，提升82%。\n片仔癀这波炒作是怎么来的呢？\n一种观点是，片仔癀稀缺。\n片仔癀真的稀缺吗？\n受疫情影响，去年开始，许多消费者对天然药材的需求增加，导致这两年天然麝香价格从每千克30万涨到40万元。片仔癀成分为牛黄、麝香、三七与蛇胆，光麝香就占到总成本的55%。\n有人认为，片仔癀原材料供应矛盾比往年更突出。作为稀缺品种，片仔癀供不应求，价格越炒越高，越高越炒，出现投资“羊群效应”。\n对于最近一次涨价原因，片仔癀在2020年1月发布公告称，鉴于主要原料及人工成本上涨等原因，公司决定自公告之日起，主导产品片仔癀锭剂国内市场零售价格从530元/粒上调到590元/粒，供应价格相应上调约40元/粒。\n然而，根据西南证券2021年2月7日发表的研报，目前片仔癀推进人工养麝，以弥补稀缺原料供给不足，陕西养殖基地养麝超1万头，推测年产超100公斤，麝香和牛黄均可满足3年的产能扩张。\n换言之，原材料的所谓稀缺是暂时的，并不支撑片仔癀的炒作。\n有黄牛炒作吗？\n4月底就有网友透露，片仔癀从2021年5月开始，正式进入限购政策，历史上最严限购令，当月凭个人身份证号码和处方，体验馆购买，一人一个月限购2粒，满足当月使用的用量，保证长期用药的客户不会断药。\n目前，多地片仔癀线下门店实行限购。需要留下电话号码和身份证号预约，甚至有线下门店要求消费者“搭配”购买，即想要买到片仔癀，还要购买其他的高价药品。\n分析师朱丹蓬表示， 片仔癀突然的紧俏，与炒作不无关系。在南方尤其是东南沿海地区，一些消费者认为片仔癀具有保健功效，而且常年价格居高不下，也因此让其有了一些礼品属性。\n一些投机者抢购片仔癀坐等涨价，再抛售之后赚取中间暴利。\n有上海的片仔癀线下门店告诉媒体，“这个药之前并没有很多人购买，两三个月前，突然有黄牛开始大批购买，店铺无奈开始限购，只对会员老顾客开放。”\n药品在与资本市场联动炒作吗？\n川财证券透露，或有游资参与片仔癀炒作。\n川财证券策略研究团队认为，突如其来的供需失衡背后难免存在有人恶意囤货，恶意炒作，甚至借机在证券市场上牟利。\n事实上，这样的炒作套路并不新鲜。今年6月，有微博认证为某资管公司总经理的用户透露，“某白酒企业邀请经销商每次进酒的时候，进等价的股票。最后股价翻了一倍，等于经销商零成本拿酒，酒还可以放好几年，慢慢卖都行。”\n2、公募基金踏空了片仔癀？\n与2020年，公募机构联手推高贵州茅台、五粮液等白酒龙头不同，这一次，吊诡的是，公募基金们可能完美踏空了“药中茅台”片仔癀。\nWind数据显示，2020年四季度末，持有片仔癀股数超过10万股的公募基金共有25家：共持有约2678.24万股，约占A股流通比例4.44%。其中不乏“顶流基金经理”葛兰、刘格菘、曲阳等人的身影。\n然而，在经历了春节之后白马股的大幅震荡之后，一季度的公开数据显示，前25家机构持股数量锐减为1002.12万股，减仓幅度超过六成，只占A股流通比例的1.65%。\n2020年底，共计有101家机构投资者持股，今年一季度末，机构投资者锐减至41家。\n2021年季度，片仔癀亦经历了股价调整，其中，2月18日至3月9日，股价从404元跌至239元，接近腰斩。\n从公开数据看，大部分公募基金在2021年1季度的调整中卖出了片仔癀。\n不过，片仔癀股价的主要上涨是在2021年2季度，在这个过程中，公募基金有没有“吃回头草”又加仓片仔癀呢？目前公募基金和上市公司的中报都尚未出炉，我们不得而知。\n2021年1季度，少数公募基金选择了坚守甚至加仓，汇添富价值精选A一股未卖继续持有150万股，而被业内称为“医药女神”的中欧葛兰则逆势大举增仓，去年四季度末还仅持有片仔癀27.28万股，而一季度末披露时已持221.49万股，足足增仓接近10倍之多，显示其对公司的强烈看好。与葛兰相同在一季度进行增仓的，还有新进的广发医疗保健（118.72万股）和社保一零一组合（104.13万股），而银华富裕主题在一季度也增仓119.98万股至274.98万股，位列第六大股东。\n3、林园是片仔癀背后的男人吗？\n2018年半年报中，私募大佬林园旗下的私募基金以0.64%的持股比例出现在了片仔癀十大股东中。截至2020年6月末，其旗下3只私募基金合计持有片仔癀股票883.7万股。\n不过，2020年第三季度传出“林园减持片仔癀”的新闻，截至2021年第一季度，林园的三支私募基金已不在十大股东之列。\n2021年6月9日，林园派了代表参加片仔癀股东大会，会上表示，“从2005年起投资片仔癀股票，至今一股未卖。”此前林园曾称，只是将持仓进行了拆分。\n林园还给片仔癀送上热情洋溢的感谢信，感谢信依然是表达强烈看好：\n“林园及林园投投资，从2005年买入片仔癀至今一股未卖。尤其在贸易战我国新冠疫情，包括今年一直在大力投入，坚持长期主义，坚定看好中医药行业，看多中国，相信国运，相信片仔癀是一家伟大的公司。相信卓越优秀的管理层。也祝愿公司在潘总的带领下。勇攀高峰成为中国的名片，成为世界的奢侈品牌！”\n此前，2018年4月21日，林园在投资报告会上甚至宣称片仔癀可以“起死回生”。\n“最近我选了一个片仔癀。也是一个药的企业，这是福建的。在漳州有两宝，一个是水仙，还有一个是片仔癀。福建人死了以后，当地人也要把这个药放进去，试试能不能活过来。”\n对于这次片仔癀的“爆炒”，林园更是公开表示“他们最终要卖到两瓶茅台的价格。”\n4、、片仔癀的涨价可否持续？\n片仔癀真的能“卖到两瓶茅台的价格吗”？\n2021年6月9日，片仔癀股东大会上，公司表示，对待涨价问题，向来都比较小心谨慎，不追求过度利润。不赞同大家拿片仔癀跟茅台的价格进行对比。茅台是粮食产品，属于食品；片仔癀是药品，药品的定价和涨价问题，要更加谨慎，更加考虑社会责任，无法马上随行就市。\n事实上，片仔癀作为药品，始终要面临医药价格管制。在医药集采的大趋势下，任何“神药”都不可能卖到天价。\n6月25日，片仔癀在互动平台回应近期其片仔癀锭剂“一粒难求”的现象，称目前公司生产经营均属于正常状态，针对近期市场情况，公司采取三方面措施，坚决维护市场秩序。\n虽然股价一飞冲天，但是，从近几年财报数据看，片仔癀在2017年的营收增速最快，达到了60.85%，但随后营收增速便开始逐年下降，到2020年下降至近五年最低点，仅有13.78%。\n不过，片仔癀的净利润始终保持较高的水平。2020年提价之后，营收增速下降至5年内最低，然时净利润增速与2019年相比，只差了1个百分点。\n事实上，片仔癀的研发费用占比很低。公司 2018 年至 2020 年研发费用分别为 1 亿元、1.19 亿元、9755 万元，占营业收入比例分别为 2.12%、2.09%、1.5%。\n片仔癀是一门“独家生意”。片仔癀与云南白药，是唯二两个国家一级中药保护品种。国家机密级别的配方药材。因此，片仔癀或许没有太强的研发动力，不试错并不会犯错。有现成可借鉴的最稳妥。","news_type":1,"symbols_score_info":{"600436":0.9}},"isVote":1,"tweetType":1,"viewCount":1895,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":9,"xxTargetLangEnum":"ORIG"},"commentList":[],"hasMoreComment":false,"orderType":2}